Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2003
09/12/2003WO2003074514A1 Alkylammonium salts of omeprazole and esomeprazole
09/12/2003WO2003074513A2 Indole amide derivatives and their use as glycogen phosphorylase inhibitors
09/12/2003WO2003074512A1 Isoquinoline derivatives
09/12/2003WO2003074508A1 Compounds and methods of treating cell proliferative diseases
09/12/2003WO2003074504A2 Process and intermediates for preparing phenylthiomethyl-thiazoles or oxazoles
09/12/2003WO2003074497A1 Pin1-modulating compounds and methods of use thereof
09/12/2003WO2003074495A1 Hppars activators
09/12/2003WO2003074490A1 9-aminoacridine derivatives and process for the preparation thereof
09/12/2003WO2003074489A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
09/12/2003WO2003074486A1 Azaspiro compounds for the treatment of pain
09/12/2003WO2003074485A2 Indole-amide derivatives and their use as glycogen phosphorylase inhibitors
09/12/2003WO2003074484A1 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
09/12/2003WO2003074479A1 Semicarbazide derivatives and their use as antithrombotics
09/12/2003WO2003074476A1 Novel arylamidine derivative or salt thereof
09/12/2003WO2003074474A2 Multiple-component solid phases containing at least one active pharmaceutical ingredient
09/12/2003WO2003074473A2 Irreversible selective androgen receptor modulators and methods of use thereof
09/12/2003WO2003074471A1 Haloacetamide and azide substituted compounds and methods of use thereof
09/12/2003WO2003074469A1 Novel cinnamate salts, method for production and use thereof as medicaments
09/12/2003WO2003074467A2 Urea derivatives as hiv aspartyl protease inhibitors
09/12/2003WO2003074108A2 Compositions for generating submucosal fluid cushions
09/12/2003WO2003074101A1 Method of treating atherosclerosis and hypercholesterolemia
09/12/2003WO2003074098A1 Modified phosphocalcic compound, injectable composition containing same
09/12/2003WO2003074086A1 Liquid matrix undergoing phase transfer in vivo and liquid oral preparations
09/12/2003WO2003074085A1 Tablets quickly disintegrating in oral cavity
09/12/2003WO2003074084A1 A pharmaceutical composition
09/12/2003WO2003074083A1 Combination therapies for treating methylthioadenosine phosphorylase deficient cells
09/12/2003WO2003074082A1 Formulations and methods of using nitric oxide mimetics in cancer treatment
09/12/2003WO2003074080A1 Treatment of central nervous system damage
09/12/2003WO2003074078A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
09/12/2003WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003WO2003074072A1 Methods and compositions for the treatment of ischemia
09/12/2003WO2003074070A1 Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties
09/12/2003WO2003074067A1 Compositions of and derived from strawberry and raspberry and therapeutic uses therefor
09/12/2003WO2003074065A1 Identification of free-b-ring flavonoids as potent cox-2 inhibitors
09/12/2003WO2003074062A2 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
09/12/2003WO2003074061A1 Electrolyte purgative
09/12/2003WO2003074060A2 Dna demethylase antisense and chemotherapy combination
09/12/2003WO2003074059A2 Materials and methods relating to the treatment of lymphoma
09/12/2003WO2003074058A1 Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery
09/12/2003WO2003074057A1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
09/12/2003WO2003074055A1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
09/12/2003WO2003074053A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
09/12/2003WO2003074052A1 Thiazole and oxazole derivatives that modulate ppar activity
09/12/2003WO2003074051A1 Substituted thiazoles and oxazoles that modulate ppar activity
09/12/2003WO2003074050A1 Thiazole and oxazole derivatives which modulate ppar activity
09/12/2003WO2003074049A1 Antitumor agents
09/12/2003WO2003074048A1 Method of treating osteoarthritis
09/12/2003WO2003074045A1 Antitumor agent comprising combination of sulfonamide-containing heterocyclic compound with angiogenesis inhibitor
09/12/2003WO2003074044A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
09/12/2003WO2003074043A1 Body temperature elevating agents
09/12/2003WO2003074042A1 Uncoupling protein expression promoter
09/12/2003WO2003074041A1 Pharmaceutical compositions
09/12/2003WO2003074040A1 Compositions for ameliorating fecal properties
09/12/2003WO2003074039A1 Compositions for preventing hypertension
09/12/2003WO2003074038A1 Methods for treating diseases related to intraocular pressure
09/12/2003WO2003074037A1 Treatment of female sexual dysfunction
09/12/2003WO2003074036A1 Novel formulation
09/12/2003WO2003074034A1 Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release
09/12/2003WO2003074033A1 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
09/12/2003WO2003074032A1 Oral administration form for difficulty soluble basic active ingredients which are applied orally
09/12/2003WO2003074029A1 Fast melt multiparticulate formulations for oral delivery
09/12/2003WO2003074027A2 Self emulsifying drug delivery systems for poorly soluble drugs
09/12/2003WO2003074025A2 Pressurised metered dose inhalers containing solutions of beta-2 agonists
09/12/2003WO2003074023A1 Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
09/12/2003WO2003074019A1 Whitening cosmetic composition
09/12/2003WO2003074013A1 Use of sugar esters in cosmetic and/or pharmaceutical preparations
09/12/2003WO2003074008A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003074006A2 Compositions and methods for preventing sporadic neoplasia in colon
09/12/2003WO2003074002A2 Methods of treating pin1 associated disorders
09/12/2003WO2003073999A2 Pini-modulating compounds and methods of use thereof
09/12/2003WO2003073997A2 Treatment of septic shock
09/12/2003WO2003073991A2 Methods to increase or decrease bone density
09/12/2003WO2003073990A2 Treatment for asthma or allergies
09/12/2003WO2003073989A2 Nucleoside 5'-monophosphate mimics and their prodrugs
09/12/2003WO2003073988A2 Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
09/12/2003WO2003073987A2 Compounds that modulate the activity of ptp-1b and tc-ptp
09/12/2003WO2003073986A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003073985A2 New methods of using antiangiogenic agents
09/12/2003WO2003073983A2 Methods and compositions in treating pain using diacylglycerol kinase epsilon
09/12/2003WO2003073981A2 Novel of cytokine inhibitors
09/12/2003WO2003073979A2 Derivatives of azaspiro compounds for the treatment of pain
09/12/2003WO2003073918A2 Prevention of recurrence and metastasis of cancer
09/12/2003WO2003053356A3 APOMORPHINE INHIBITORS OF AMYLOID-β (Aβ) FIBRIL FORMATION AND THEIR USE IN AMYLOIDOSIS BASED DISEASE
09/12/2003WO2003051828A3 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
09/12/2003WO2003051374A3 SEQUESTRATION OF Aβ IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
09/12/2003WO2003051333B1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
09/12/2003WO2003048081A3 Glycinamides as factor xa inhibitors
09/12/2003WO2003047524A3 Methods and compositions for modulating the immune system and uses thereof
09/12/2003WO2003045940A3 Benzazepine derivatives and their use as 5-ht ligands
09/12/2003WO2003045272A3 ORAL IMMUNOSTIMULATION OF MAMMALS, BIRDS, FISH AND REPTILES FROM (1-4) LINKED ß-D-MANNURONIC ACID
09/12/2003WO2003041684A3 Injectable depot compositions and uses thereof
09/12/2003WO2003039596B1 Photodynamic therapy for the treatment of hair loss
09/12/2003WO2003039559B1 Pharmaceutical combinatons comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
09/12/2003WO2003034987A3 Androgen receptor modulators and methods of use thereof
09/12/2003WO2003033027A3 Dendrimers for use in targeted delivery
09/12/2003WO2003033014A3 Novel use of pulmonary surfactant
09/12/2003WO2003032969A3 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications
09/12/2003WO2003028710A3 Compounds for reducing excessive intake of food
09/12/2003WO2003020701A9 Multi-use multimodal imaging chelates
09/12/2003WO2003017932B1 Compositions and methods for targeting cerebral circulation and treatment of headache
1 ... 5344 5345 5346 5347 5348 5349 5350 5351 5352 5353 5354 5355 5356 5357 5358 5359 5360 5361 5362 5363 5364 ... 7860